These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 29486012

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K, Nakamura S, Sugiyama T, Kadomatsu Y, Ueno H, Goto M, Ozeki N, Fukui T, Iwano S, Chen-Yoshikawa TF.
    BMC Cancer; 2021 Sep 02; 21(1):983. PubMed ID: 34474680
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
    Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, Ueda K, Tanaka N, Matsunaga N.
    Ann Nucl Med; 2009 Aug 02; 23(6):523-31. PubMed ID: 19444550
    [Abstract] [Full Text] [Related]

  • 6. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
    Shigemoto Y, Suga K, Matsunaga N.
    Ann Nucl Med; 2016 May 02; 30(4):287-97. PubMed ID: 27007128
    [Abstract] [Full Text] [Related]

  • 7. [18F]FAPI adds value to [18F]FDG PET/CT for diagnosing lymph node metastases in stage I-IIIA non-small cell lung cancer: a prospective study.
    Li Y, Zhang Y, Guo Z, Hou P, Lv J, Ke M, Liu S, Li S, Yin W, He J, Wang X.
    Cancer Imaging; 2024 Jun 03; 24(1):68. PubMed ID: 38831354
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [18F]FDG-PET/CT parameters.
    Rogasch JMM, Michaels L, Baumgärtner GL, Frost N, Rückert JC, Neudecker J, Ochsenreither S, Gerhold M, Schmidt B, Schneider P, Amthauer H, Furth C, Penzkofer T.
    Eur J Nucl Med Mol Imaging; 2023 Jun 03; 50(7):2140-2151. PubMed ID: 36820890
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
    Mattes MD, Moshchinsky AB, Ahsanuddin S, Rizk NP, Foster A, Wu AJ, Ashamalla H, Weber WA, Rimner A.
    Clin Lung Cancer; 2015 Nov 03; 16(6):e253-8. PubMed ID: 26163919
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.
    Biomed Mater Eng; 2014 Nov 03; 24(6):3091-103. PubMed ID: 25227018
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer.
    Shinya T, Rai K, Okumura Y, Fujiwara K, Matsuo K, Yonei T, Sato T, Watanabe K, Kawai H, Sato S, Kanazawa S.
    Clin Nucl Med; 2009 Apr 03; 34(4):216-21. PubMed ID: 19300050
    [Abstract] [Full Text] [Related]

  • 18. The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients.
    Choi EK, Park HL, Yoo IR, Kim SJ, Kim YK.
    Eur Radiol; 2020 Jan 03; 30(1):442-451. PubMed ID: 31338654
    [Abstract] [Full Text] [Related]

  • 19. Quantitative computed tomography texture analysis: can it improve diagnostic accuracy to differentiate malignant lymph nodes?
    Shin SY, Hong IK, Jo YS.
    Cancer Imaging; 2019 May 22; 19(1):25. PubMed ID: 31113494
    [Abstract] [Full Text] [Related]

  • 20. [Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer].
    Shao T, Yu L, Li Y, Chen M.
    Zhongguo Fei Ai Za Zhi; 2015 Mar 22; 18(3):155-60. PubMed ID: 25800571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.